2008•Journal of clinical lipidologyRequires access

Effect of ezetimibe/simvastatin versus atorvastatin or rosuvastatin on modifying lipid profiles in patients with diabetes, metabolic syndrome, or neither: Results of two subgroup analyses

Nicola I. Abate, Alberico Luigi Catapano, Christie Mitchell Ballantyne, Michael H. Davidson, Adam B. Polis, Steven S. Smugar, Andrew M. Tershakovec

Open publisher page 25 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 25 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Rosuvastatin, Atorvastatin, Medicine, Simvastatin, Ezetimibe, Internal medicine, Apolipoprotein B, National Cholesterol Education Program